Congenital cytomegalovirus infection: clinical outcome
- PMID: 24257422
- PMCID: PMC4471438
- DOI: 10.1093/cid/cit629
Congenital cytomegalovirus infection: clinical outcome
Abstract
Congenital cytomegalovirus (CMV) infection is a leading cause of hearing loss and neurologic disabilities in children worldwide. Infants with symptomatic congenital CMV infection at birth are at significantly increased risk for developing adverse long-term outcomes. The vast majority of infants with congenital CMV infection have no clinical findings at birth (asymptomatic infants), and about 10%-15% of these children develop long-term sequelae. Currently, predictors of adverse outcome in asymptomatic congenital CMV infection are not known, and it is important that future studies address this issue.
Keywords: congenital; cytomegalovirus; outcome; sensorineural hearing loss.
References
-
- Britt WJ. Cytomegalovirus. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, editors. Infectious diseases of the fetus and newborn infant. Philadelphia: Elsevier Saunders; 2011. pp. 706–55.
-
- Morton CC, Nance WE. Newborn hearing screening—a silent revolution. N Engl J Med. 2006;354:2151–64. - PubMed
-
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63. - PubMed
-
- Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2005;35:226–31. - PubMed
-
- Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992;11:93–9. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical